Staff Investigator - Turkson

$15,163P30FY2013CANIH

University Of Hawaii At Manoa, Honolulu HI

Investigators

Linked publications & trials

Paper 39456556 Paper 39408372 Paper 39164784 Paper 39108521 Paper 39101843 Paper 39070747 Paper 39024224 Paper 38780906 Paper 38629963 Paper 38584295 Paper 38541323 Paper 38487799 Paper 38474168 Paper 38425005 Paper 38408450 Paper 38397661 Paper 38367619 Paper 38345843 Paper 38303608 Paper 38294036 Paper 38291891 Paper 38287144 Paper 38284815 Paper 38259353 Paper 38254887 Paper 38243693 Paper 38218711 Paper 38212077 Paper 38180474 Paper 38097807 Paper 38024651 Paper 37982329 Paper 37877788 Paper 37860916 Paper 37850323 Paper 37748715 Paper 37676833 Paper 37662282 Paper 37624834 Paper 37623205 Paper 37580793 Paper 37571419 Paper 37562772 Paper 37555836 Paper 37406880 Paper 37336095 Paper 37108716 Paper 37029080 Paper 36948887 Paper 36934308 Paper 36902377 Paper 36841805 Paper 36826816 Paper 36812216 Paper 36758897 Paper 36694222 Paper 36684450 Paper 36684445 Paper 36622766 Paper 36608311 Paper 36607984 Paper 36600333 Paper 36600297 Paper 36593337 Paper 36576985 Paper 36572991 Paper 36555339 Paper 36495151 Paper 36485021 Paper 36477530 Paper 36473671 Paper 36450776 Paper 36443779 Paper 36418803 Paper 36350738 Paper 36344807 Paper 36328784 Paper 36306381 Paper 36253659 Paper 36215110 Paper 36191897 Paper 36182917 Paper 36149056 Paper 36145211 Paper 36126957 Paper 36118154 Paper 36057968 Paper 36041186 Paper 36014772 Paper 36004645 Paper 35998368 Paper 35970742 Paper 35927738 Paper 35894079 Paper 35892120 Paper 35867953 Paper 35854938 Paper 35842542 Paper 35834270 Paper 35820496

Abstract

The University of Hawaii Cancer Center is requesting partial support for two (2) Staff Investigators, each of whom will focus on a strategic research/clinical area of major interest to the Cancer Center. James Turkson, PhD, a recent recruit to the University of Hawaii Cancer Center from the Moffit Cancer Center and the University of Central Florida, will lead the creation of a robust drug development initiative within the Cancer Biology Program with the goal of building scientific collaborations focused on translational research involving Cancer Center members from both the basic science programs and our clinical partners. Dr. Turkson has extensive experience in drug development having spent more than a decade designing and evaluating small molecule inhibitors of the signaling transducer and activator of transcription-3 (STAT-3) protein. STAT-3 mediates the expression of a variety of genes in response to cell stimuli and plays a key role in many cellular processes, including the initiation and progression of various human cancers. Dr. Turkson has published over 50 peer reviewed papers and co-authored 4 issued patents and 8 provisional and pending patents in the field.

View original record on NIH RePORTER →